SecBot SecBot
8-K ·Filed Apr 30, 2026

NXGLW

NEXGEL, INC.
NEUTRAL
Impact 2/10
Horizonweeks Processed6mo ago SEC0001493152-26-020657
8-K context-dependent: Items 5.02, 8.01
Actionable Insight • Neutral

Monitor next 10-Q for any financial impact from the Celularity acquisition referenced in the press release, but this filing itself has no trading implications.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d
NXGLW ▲ 0.00% at T+20d
NEUTRAL call 0.00% · α vs SPY -5.27% · entry $0.0550 → $0.0550
Next anchor: T+60d due 3mo ago
Entry = T+0 close
Apr 30, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.34%
$0.0550
settled 6mo ago
T+5d
0.00%
call 0.00% · α -2.35%
$0.0550
settled 6mo ago
T+20d
0.00%
call 0.00% · α -5.27%
$0.0550
settled 5mo ago
T+60d
Pending
due 3mo ago

Price Chart

Loading chart...

Executive Summary

NEXGEL appointed Ian Blackman as permanent CFO, replacing interim CFO Adam Drapczuk, with a $250,000 base salary and 160,000 stock options. The filing is a routine executive appointment with no financial data or material events — neutral for the stock.

Key Facts

  • Ian Blackman appointed CFO effective April 27, 2026, replacing interim CFO Adam Drapczuk
  • Base salary of $250,000 per year
  • Initial option grant of 160,000 shares under 2019 Long-Term Incentive Plan
  • Cash bonus tied to 2026 EBITDA targets: 10% of salary at $4M EBITDA, 30% at $6M, 50% at $8M
  • No financial results, guidance, or material operational updates disclosed

Financial Impact

No financial impact disclosed — routine executive compensation arrangement

Risk Factors

  • No financial data or guidance provided — limited information for valuation
  • Celularity acquisition integration risk mentioned in press release but no deal terms disclosed

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-020657
Exhibit: ex99-1.htm0001493152-26-020657
Document: form8-k.htm0001493152-26-020657
Document: 0001493152-26-020657-index-headers.html0001493152-26-020657
Document: 0001493152-26-020657-index.html0001493152-26-020657
Document: 0001493152-26-020657.txt0001493152-26-020657
4 reports for NXGLW
Performance horizon
67% Hit rate @ T+20 2 of 3 directional calls Went positive at some point 3 of 3 best @ T+60▲ +52.55%Apr 21, 2026
Filters
Rows
Reports for NXGLW — sortable, filterable
TypeNow
May 15, 2026
23w ago
8-K
BEARISH ★ 7/10
$0.0550 $0.0387▲ +29.64%▲ +31.22%—
Apr 30, 2026
25w ago
8-K
NEUTRAL ★ 2/10
$0.0550 $0.0550· 0.00%▼ −5.27%—
Apr 24, 2026
26w ago
8-K
BEARISH ★ 8/10
$0.0550 $0.0538▲ +2.18%▲ +7.14%—
Apr 21, 2026
27w ago
8-K
BEARISH ★ 7/10
$0.0550 $0.0550· 0.00%▲ +3.17%—
Showing 4 of 4

US Market Status

Market Closed — Opens Thu (13h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 30, 2026